Shu‐Hui Liu

2.6k total citations
53 papers, 1.2k citations indexed

About

Shu‐Hui Liu is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shu‐Hui Liu has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Molecular Biology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shu‐Hui Liu's work include Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (6 papers) and Immunotherapy and Immune Responses (5 papers). Shu‐Hui Liu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (6 papers) and Immunotherapy and Immune Responses (5 papers). Shu‐Hui Liu collaborates with scholars based in China, United States and Taiwan. Shu‐Hui Liu's co-authors include Frances M. Brodsky, Xiaobin Lü, Haifeng Yu, B. Matija Peterlin, Charles S. Craik, Mei Lie Wong, Pavel Strop, Arvind Rajpal, Kathy Delaria and Russell G. Dushin and has published in prestigious journals such as Cell, Journal of Clinical Oncology and Blood.

In The Last Decade

Shu‐Hui Liu

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu‐Hui Liu China 15 471 435 291 276 164 53 1.2k
Elena Tanghetti Italy 16 810 1.7× 233 0.5× 287 1.0× 72 0.3× 266 1.6× 23 1.3k
Sunil J. Advani United States 28 717 1.5× 619 1.4× 280 1.0× 145 0.5× 61 0.4× 55 1.8k
Ronald Q. Warren United States 12 732 1.6× 602 1.4× 190 0.7× 54 0.2× 82 0.5× 18 1.4k
Odile Berthier‐Vergnes France 23 711 1.5× 319 0.7× 473 1.6× 108 0.4× 201 1.2× 46 1.6k
M.H.F. Sullivan United Kingdom 22 598 1.3× 155 0.4× 164 0.6× 336 1.2× 82 0.5× 42 1.5k
Lap-Ping Chung United Kingdom 21 423 0.9× 297 0.7× 585 2.0× 156 0.6× 47 0.3× 27 1.4k
David B. Durand United States 8 1.2k 2.5× 351 0.8× 829 2.8× 111 0.4× 75 0.5× 11 1.8k
Theodora W. Salcedo United States 18 403 0.9× 495 1.1× 931 3.2× 237 0.9× 46 0.3× 30 1.5k
Anthony Secreto United States 9 697 1.5× 247 0.6× 415 1.4× 29 0.1× 251 1.5× 15 1.4k
Lioudmila Tchistiakova United States 22 603 1.3× 359 0.8× 403 1.4× 634 2.3× 69 0.4× 30 1.4k

Countries citing papers authored by Shu‐Hui Liu

Since Specialization
Citations

This map shows the geographic impact of Shu‐Hui Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Hui Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Hui Liu more than expected).

Fields of papers citing papers by Shu‐Hui Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Hui Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Hui Liu. The network helps show where Shu‐Hui Liu may publish in the future.

Co-authorship network of co-authors of Shu‐Hui Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Hui Liu. A scholar is included among the top collaborators of Shu‐Hui Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Hui Liu. Shu‐Hui Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coward, Jermaine, Ganessan Kichenadasse, John Park, et al.. (2024). Preliminary results from a first-in-human trial of AMT-116, a topoisomerase I inhibitor containing antibody-drug conjugate (ADC), in patients with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). e15010–e15010.
2.
Zhang, Lina, Yihan Li, Yue Zhang, et al.. (2024). Identification of lncRNA dual targeting PD-L1 and PD-L2 as a novel prognostic predictor for gastric cancer. Frontiers in Oncology. 14. 1341056–1341056.
3.
Liu, Shu‐Hui, et al.. (2024). The effects of Qingchang Ligan formula on hepatic encephalopathy in mouse model: results from gut microbiome-metabolomics analysis. Frontiers in Cellular and Infection Microbiology. 14. 1381209–1381209. 2 indexed citations
4.
Liu, Shu‐Hui, Tao Jing, Ran Jia, Jilong Zhang, & Fu‐Quan Bai. (2024). MD investigation on the differences in the dynamic interactions between the specific ligand azamulin and two CYP3A isoforms, 3A4 and 3A5. Journal of Biomolecular Structure and Dynamics. 43(17). 9589–9598. 1 indexed citations
5.
6.
Zhang, Ru, Shu‐Hui Liu, Ping Tan, et al.. (2023). Effect of the CYBA C242T Polymorphism on Preeclampsia Pathogenesis in the Chinese Population. Biochemical Genetics. 62(3). 1675–1689. 1 indexed citations
7.
Gao, Xiaona, Shu‐Hui Liu, Chenchen Ding, et al.. (2021). Comparative effects of genistein and bisphenol A on non-alcoholic fatty liver disease in laying hens. Environmental Pollution. 288. 117795–117795. 30 indexed citations
8.
Chen, Guangcan, Jingyao Chen, Liangli Hong, et al.. (2018). Clinicopathological Features and Increased Expression of Toll-Like Receptor 4 of Gastric Cardia Cancer in a High-Risk Chinese Population. Journal of Immunology Research. 2018. 1–10. 14 indexed citations
9.
Wong, Oi Kwan, Thomas-Toan Tran, Wei-Hsien Ho, et al.. (2018). RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models. Oncotarget. 9(71). 33446–33458. 20 indexed citations
10.
Chen, Guangcan, Shu‐Hui Liu, & Liangli Hong. (2017). Analysis of 575 cases of gastric cardia pathological changes in Chaoshan gastric cardia cancer high risk area. Zhongguo jiceng yiyao. 24(6). 801–804.
11.
Kashyap, Manoj Kumar, Deepak Kumar, Brett H. Simmons, et al.. (2017). Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia. Journal of Hematology & Oncology. 10(1). 112–112. 49 indexed citations
12.
DeVay, Rachel M., Kathy Delaria, Guoyun Zhu, et al.. (2017). Improved Lysosomal Trafficking Can Modulate the Potency of Antibody Drug Conjugates. Bioconjugate Chemistry. 28(4). 1102–1114. 42 indexed citations
13.
Liu, Shu‐Hui, Guangcan Chen, Haihua Huang, et al.. (2017). Patrilineal background of the She minority population from Chaoshan Fenghuang Mountain, an isolated mountain region, in China. Genomics. 109(3-4). 284–289. 7 indexed citations
14.
Strop, Pavel, Thomas-Toan Tran, Magdalena Dorywalska, et al.. (2016). RN927C, a Site-Specific Trop-2 Antibody–Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models. Molecular Cancer Therapeutics. 15(11). 2698–2708. 78 indexed citations
15.
Dorywalska, Magdalena, Russell G. Dushin, Ludivine Moine, et al.. (2016). Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design. Molecular Cancer Therapeutics. 15(5). 958–970. 162 indexed citations
16.
Liu, Shu‐Hui, Ying Zhang, Chao Bi, et al.. (2014). Helicobacter pylori infection and gastric cardia cancer in Chaoshan region. Microbes and Infection. 16(10). 840–844. 14 indexed citations
17.
Miyatake, Takashi, Barbara Tringler, Wenhui Liu, et al.. (2007). B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration. Gynecologic Oncology. 106(1). 119–127. 95 indexed citations
18.
Liu, Shu‐Hui, et al.. (2005). A novel splice variant of human Ep-CAM as a potential therapeutic antibody target for epithelial cell-based cancers. Cancer Research. 65. 636–637. 1 indexed citations
19.
Lü, Xiaobin, Haifeng Yu, Shu‐Hui Liu, Frances M. Brodsky, & B. Matija Peterlin. (1998). Interactions between HIV1 Nef and Vacuolar ATPase Facilitate the Internalization of CD4. Immunity. 8(5). 647–656. 218 indexed citations
20.
Liu, Shu‐Hui, Mei Lie Wong, Charles S. Craik, & Frances M. Brodsky. (1995). Regulation of clathrin assembly and trimerization defined using recombinant triskelion hubs. Cell. 83(2). 257–267. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Tanghetti Breakdown of academic impact, for papers by Sunil J. Advani Breakdown of academic impact, for papers by Ronald Q. Warren Breakdown of academic impact, for papers by Odile Berthier‐Vergnes Breakdown of academic impact, for papers by M.H.F. Sullivan Breakdown of academic impact, for papers by Lap-Ping Chung Breakdown of academic impact, for papers by David B. Durand Breakdown of academic impact, for papers by Theodora W. Salcedo Breakdown of academic impact, for papers by Anthony Secreto Breakdown of academic impact, for papers by Lioudmila Tchistiakova
Rankless by CCL
2026